RESEARCHER PROFILE
Derya Tilki
D
Universität Hamburg
Derya Tilki works in Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Breast Cancer Treatment Studies, Bladder and Urothelial Cancer Treatments, Urinary Bladder and Prostate Research. Recorded institutional associations include Koç University, Universität Hamburg, University Medical Center Hamburg-Eppendorf.
1,010Publications
24,227Citations
70H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
2020 · 2,802 citationsEAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent
2024 · 1,246 citationsEAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
2020 · 1,079 citationsThe Lancet Commission on prostate cancer: planning for the surge in cases
2024 · 738 citationsPrognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
2018 · 523 citationsEAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer
2024 · 352 citationsBiochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations
2019 · 247 citationsEAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
2019 · 243 citationsDiscrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
2011 · 212 citationsTargeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
2014 · 212 citationsCharacteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort
2009 · 201 citationsSoft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients
2010 · 194 citationsUrine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
2011 · 186 citationsBiomarkers in prostate cancer – Current clinical utility and future perspectives
2017 · 167 citationsManagement of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
2023 · 166 citationsNerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical Prostatectomy
2015 · 164 citationsExternal Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort
2019 · 158 citationsBenefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
2020 · 149 citationsInternational validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
2010 · 144 citationsSalvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review
2018 · 143 citationsQuality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron‐sparing surgery in patients with renal cell carcinoma
2009 · 142 citationsManagement of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
2024 · 135 citationsAssociation Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
2011 · 134 citationsManagement of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
2022 · 130 citationsPersistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes
2019 · 126 citations
